Active Ingredient: ETHINYL ESTRADIOL; LEVONORGESTREL
Proprietary Name: TWIRLA
Dosage Form; Route of Administration: SYSTEM; TRANSDERMAL
Strength: 0.03MG/24HR;0.12MG/24HR
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N204017
Product Number: 001
Approval Date: Feb 14, 2020
Applicant Holder Full Name: AGILE THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
